HomeNDC LookupRxCUI directory › RxCUI 2596864

Sirolimus 0.002 MG/MG Topical Gel — RxCUI 2596864

RxNorm drug concept · Semantic clinical drug
RxCUI 2596864 Semantic clinical drug · SCD ● Current RxNorm concept 1 FDA product 1 package NDC Snapshot Jul 14, 2026

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI2596864
Official nameSirolimus 0.002 MG/MG Topical Gel
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known assirolimus 0.2 % Topical Gel
FDA products mapped1
Package NDCs mapped1
Reported Medicaid activity (SDUD)2,154 prescriptions · 21 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Sirolimus: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Sirolimus comes in a few different forms, and each one has its own approved use. The oral tablets and liquid are mainly used to prevent kidney transplant rejection and to treat a r...
  • What exactly is sirolimus being used for — I've seen it listed for so many different things?
  • Yes, it matters — but not in the way you might think. You don't have to eat with it, but you do need to be consistent. Food, especially a high-fat meal, can increase how much sirol...
  • Does it matter if I take my oral sirolimus with food or without?
📖 Read our full Sirolimus guide →

🕸️ Concept Web — How Sirolimus 0.002 MG/MG Topical Gel Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Sirolimus 0.002 MG/MG Topical Gel RxCUI 2596864

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Sirolimus 35302
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Hyftor 2596865
  3. Dose forms 6

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Sirolimus Topical Gel 2596863
    • Sirolimus Topical Product 2596862
    • Sirolimus Topical Gel [Hyftor] 2596868
    • Hyftor Topical Product 2596867
    • Topical Gel 346286
    • Topical Product 1151122
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 11 of 11 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Sirolimus 0.002 MG/MG SCDC · 2596861
  • Sirolimus Topical Gel SCDF · 2596863
  • Sirolimus Topical Product SCDG · 2596862

Brand-Name Concepts

  • Sirolimus 0.002 MG/MG Topical Gel [Hyftor] SBD · 2596869
  • Sirolimus 0.002 MG/MG [Hyftor] SBDC · 2596866
  • Sirolimus Topical Gel [Hyftor] SBDF · 2596868
  • Hyftor Topical Product SBDG · 2596867
  • Hyftor BN · 2596865

📦 FDA Products & Package NDCs

1 product · 1 package NDC
1 package NDC map to RxCUI 2596864 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
73683-0101-10 1 TUBE in 1 CARTON (73683-101-10) / 10 g in 1 TUBE HYFTOR Nobelpharma America, LLC 2022-03-23
Observed labelers: Nobelpharma America, LLC (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.